down arrow

Chemed Corp.

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: US16359R1032
USD
424.30
-6.53 (-1.52%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

421.30430.00

52 Week

408.42623.61
Valuation
Technical
Day's Volume

CASH

126.48 k

Shareholding (Mar 2025)

FII

17.78%

Held by 223 FIIs

DII

41.47%

Held by 43 DIIs

Promoter

0.01%

How big is Chemed Corp.?

22-Jun-2025

As of Jun 18, Chemed Corp. has a market capitalization of $19.62 billion, with net sales of $2.49 billion and a net profit of $308.75 million over the last four quarters.

Market Cap: As of Jun 18, Chemed Corp. has a market capitalization of 19,624.38 million, categorizing it as a Mid Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Chemed Corp. reported net sales of 2,488.99 million and a net profit of 308.75 million.<BR><BR>Balance Sheet Snapshot: As of Dec'24, the company reported shareholder's funds of 1,118.99 million and total assets of 1,767.37 million.

Read More

What does Chemed Corp. do?

22-Jun-2025

Chemed Corp. operates in the hospital industry, offering hospice and palliative care services through VITAS and plumbing services via Roto-Rooter. As of March 2025, it reported net sales of $647 million and a market cap of approximately $19.62 billion.

Overview:<BR>Chemed Corp. operates in the hospital industry, providing hospice and palliative care services through its VITAS segment and plumbing services through its Roto-Rooter segment, and it falls within the mid-cap market category.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 647 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 72 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 19,624.38 Million (Mid Cap)<BR><BR>Key Metrics:<BR>P/E: 65.00 <BR>Dividend Yield: 0.15% <BR>Debt Equity: -0.11 <BR>Return on Equity: 26.14% <BR>Price to Book: 16.61<BR><BR>Contact Details:<BR>Address: 255 E 5th St Ste 2600, CINCINNATI OH: 45202-4138 <BR>Tel: 1 513 7626690 <BR>Website: http://www.chemed.com

Read More

Who are in the management team of Chemed Corp.?

22-Jun-2025

As of March 2022, the management team of Chemed Corp. includes Mr. Kevin McNamara (CEO), Mr. George Walsh (Independent Chairman), and several independent directors: Mr. Thomas Hutton, Mr. Joel Gemunder, Mr. Patrick Grace, Mr. Walter Krebs, and Dr. Andrea Lindell.

As of March 2022, the management team of Chemed Corp. includes the following individuals:<BR><BR>- Mr. George Walsh, Independent Chairman of the Board<BR>- Mr. Kevin McNamara, President, Chief Executive Officer, Director<BR>- Mr. Thomas Hutton, Director<BR>- Mr. Joel Gemunder, Independent Director<BR>- Mr. Patrick Grace, Independent Director<BR>- Mr. Walter Krebs, Independent Director<BR>- Dr. Andrea Lindell, Independent Director<BR><BR>This team comprises a mix of independent directors and executive leadership, with Mr. McNamara serving as the CEO.

Read More

Is Chemed Corp. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, Chemed Corp. is considered very expensive and overvalued with a P/E ratio of 65 and an EV to EBITDA of 44.10, significantly higher than industry averages, while underperforming the S&P 500 with a year-to-date return of -16.84%.

As of 17 October 2025, the valuation grade for Chemed Corp. has moved from fair to very expensive, indicating that the stock is overvalued. The company exhibits a P/E ratio of 65, a Price to Book Value of 16.99, and an EV to EBITDA ratio of 44.10, all of which are significantly higher than industry averages. In comparison, Universal Health Services, Inc. has a P/E ratio of 9.20 and an EV to EBITDA of 6.78, while National HealthCare Corp. shows a fair valuation with a P/E of 18.51 and an EV to EBITDA of 9.12.<BR><BR>Recent performance shows that Chemed Corp. has underperformed against the S&P 500, with a year-to-date return of -16.84% compared to the S&P 500's 13.30%. This further reinforces the notion that the stock is overvalued given its high valuation ratios and poor relative performance.

Read More

Is Chemed Corp. technically bullish or bearish?

28-Oct-2025

As of October 24, 2025, Chemed Corp. is in a bearish trend, indicated by bearish daily moving averages and Bollinger Bands, with mixed signals from MACD and KST, and has significantly underperformed the S&P 500 with a year-to-date return of -17.59%.

As of 24 October 2025, the technical trend for Chemed Corp. has changed from mildly bearish to bearish. The current stance is bearish, with key indicators supporting this view including a bearish signal from the daily moving averages and both weekly and monthly Bollinger Bands. The MACD shows a mildly bullish signal on the weekly but is bearish on the monthly, indicating mixed signals across time frames. The KST is mildly bullish weekly but bearish monthly, while the Dow Theory presents a mildly bearish weekly and mildly bullish monthly stance. <BR><BR>In terms of performance, Chemed Corp. has underperformed the S&P 500 across all multi-period returns, with a year-to-date return of -17.59% compared to the S&P 500's 15.47%, and a one-year return of -26.85% versus 16.90% for the index.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

High Management Efficiency with a high ROE of 28.67%

 
2

Company has a low Debt to Equity ratio (avg) at times

 
3

Poor long term growth as Net Sales has grown by an annual rate of 4.45% and Operating profit at 5.82% over the last 5 years

 
4

Flat results in Jun 25

5

With ROE of 26.14%, it has a very expensive valuation with a 16.99 Price to Book Value

6

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Hospital

stock-summary
Market cap

USD 16,532 Million (Small Cap)

stock-summary
P/E

65.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.19%

stock-summary
Debt Equity

-0.17

stock-summary
Return on Equity

24.24%

stock-summary
Price to Book

13.79

Revenue and Profits:
Net Sales:
619 Million
(Quarterly Results - Jun 2025)
Net Profit:
52 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.7%
0%
-7.7%
6 Months
-24.45%
0%
-24.45%
1 Year
-25.48%
0%
-25.48%
2 Years
-26.69%
0%
-26.69%
3 Years
-19.04%
0%
-19.04%
4 Years
-9.72%
0%
-9.72%
5 Years
-10.47%
0%
-10.47%

Chemed Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Chemed Corp. Experiences Revision in Stock Evaluation Amid Mixed Market Signals

Chemed Corp. Experiences Revision in Stock Evaluation Amid Mixed Market Signals

Chemed Corp., a small-cap hospital industry player, has experienced stock fluctuations, with a current price of $436.78. The company has faced challenges, underperforming the S&P 500 over the past year and year-to-date. Technical indicators present mixed signals, suggesting a cautious outlook for the stock.

Read More

Is Chemed Corp. technically bullish or bearish?

As of 24 October 2025, the technical trend for Chemed Corp. has changed from mildly bearish to bearish. The current stance is bearish, with key indicators supporting this view including a bearish signal from the daily moving averages and both weekly and monthly Bollinger Bands. The MACD shows a mildly bullish signal on the weekly but is bearish on the monthly, indicating mixed signals across time frames. The KST is mildly bullish weekly but bearish monthly, while the Dow Theory presents a mildly bearish weekly and mildly bullish monthly stance. In terms of performance, Chemed Corp. has underperformed the S&P 500 across all multi-period returns, with a year-to-date return of -17.59% compared to the S&P 500's 15.47%, and a one-year return of -26.85% versus 16.90% for the index....

Read More

Is Chemed Corp. technically bullish or bearish?

As of 24 October 2025, the technical trend for Chemed Corp. has changed from mildly bearish to bearish. The current stance is bearish with moderate strength, driven by bearish signals across multiple indicators. The MACD is bearish on a monthly basis, while Bollinger Bands and moving averages are also indicating bearish trends. The KST shows a mildly bullish weekly signal, but overall, the weekly Dow Theory and OBV are both mildly bearish. In terms of performance, Chemed Corp. has underperformed significantly compared to the S&P 500 across all multi-period returns, with a year-to-date return of -17.59% versus the S&P 500's 15.47%, and a one-year return of -26.85% compared to the S&P 500's 16.90%....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
4.45%
EBIT Growth (5y)
5.82%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.11
Sales to Capital Employed (avg)
2.03
Tax Ratio
24.82%
Dividend Payout Ratio
9.05%
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
39.17%
ROE (avg)
28.67%
Valuation key factors
Factor
Value
P/E Ratio
65
Industry P/E
Price to Book Value
16.99
EV to EBIT
51.27
EV to EBITDA
44.10
EV to Capital Employed
18.98
EV to Sales
8.02
PEG Ratio
6.80
Dividend Yield
0.15%
ROCE (Latest)
37.01%
ROE (Latest)
26.14%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 125 Schemes (40.74%)

Foreign Institutions

Held by 223 Foreign Institutions (17.78%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 3.84% vs 7.60% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -25.95% vs 32.77% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "618.80",
          "val2": "595.90",
          "chgp": "3.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "84.30",
          "val2": "103.80",
          "chgp": "-18.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.40",
          "val2": "0.40",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "52.50",
          "val2": "70.90",
          "chgp": "-25.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "110.00%",
          "val2": "147.90%",
          "chgp": "-3.79%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 7.37% vs 6.06% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 10.83% vs 9.17% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,431.30",
          "val2": "2,264.40",
          "chgp": "7.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "436.00",
          "val2": "403.70",
          "chgp": "8.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.80",
          "val2": "3.10",
          "chgp": "-41.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.50",
          "val2": "-2.00",
          "chgp": "-225.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "302.00",
          "val2": "272.50",
          "chgp": "10.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "153.40%",
          "val2": "151.40%",
          "chgp": "0.20%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
618.80
595.90
3.84%
Operating Profit (PBDIT) excl Other Income
84.30
103.80
-18.79%
Interest
0.40
0.40
Exceptional Items
0.00
0.00
Consolidate Net Profit
52.50
70.90
-25.95%
Operating Profit Margin (Excl OI)
110.00%
147.90%
-3.79%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 3.84% vs 7.60% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -25.95% vs 32.77% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
2,431.30
2,264.40
7.37%
Operating Profit (PBDIT) excl Other Income
436.00
403.70
8.00%
Interest
1.80
3.10
-41.94%
Exceptional Items
-6.50
-2.00
-225.00%
Consolidate Net Profit
302.00
272.50
10.83%
Operating Profit Margin (Excl OI)
153.40%
151.40%
0.20%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 7.37% vs 6.06% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 10.83% vs 9.17% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Chemed Corp. stock-summary
stock-summary
Chemed Corp.
Hospital
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS is the provider of hospice services in an industry dominated primarily by small, non-profit, community-based hospices. VITAS provides hospice care to Medicare beneficiaries participating in these managed care programs. A portion of its VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.
Company Coordinates stock-summary
Company Details
255 E 5th St Ste 2600 , CINCINNATI OH : 45202-4138
stock-summary
Tel: 1 513 7626690
stock-summary
http://www.chemed.com
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."